Iterum Therapeutics shares fall 97.75% intraday as company files for liquidation and faces debt default, raising delisting risk, and H.C. Wainwright downgrades ITRM rating to market.

martes, 31 de marzo de 2026, 9:45 am ET1 min de lectura
ITRM--
Iterum Therapeutics fell 97.75% intraday, as the company filed for liquidation with the Irish High Court on March 27, 2026, triggering a default and increasing delisting risks. On March 30, 2026, H.C. Wainwright downgraded its ITRM rating from Buy to Neutral.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios